|Podcasts|February 22, 2018
Episode 3: Pharma's Reputation
Author(s)Michelle Maskaly, Christen Harm
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
Advertisement
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
You can listen and/or download the episode on SoundCloud or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
5